Gohealth, Inc. Financials
Gohealth, Inc. (GOCO) reported $152.8M in revenue over the twelve months to Mar 31, 2026, down 81.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
A high-gross-margin business became a financing-dependent operation when revenue fell faster than overhead and debt costs.
The most misleading improvement is liquidity optics: the current ratio reached 2.0x even as the equity cushion shrank to$37.9M . That matters because financing inflow nearly matched operating cash burn, with$122.0M coming in against$121.9M going out, so year-end cash says more about funding access than about the business funding itself.
FY2025 exposed fixed-cost deleverage: revenue dropped to
This is a light-capex but heavy-financing model: capital spending was only
Financial Health Signals
Gohealth, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Gohealth, Inc. passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Gohealth, Inc. reported a net loss of $257.1M while operations used $121.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Gohealth, Inc. reported an operating loss of $412.9M against $87.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Gohealth, Inc. generated $361.8M in revenue in fiscal year 2025. This represents a decrease of 54.7% from the prior year.
Gohealth, Inc.'s EBITDA was -$403.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 8527.4% from the prior year.
Gohealth, Inc. reported -$257.1M in net income in fiscal year 2025. This represents a decrease of 8675.8% from the prior year.
Cash & Balance Sheet
Gohealth, Inc. recorded an outflow of $130.2M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 268.4% from the prior year.
Gohealth, Inc. held $32.9M in cash against $636.7M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Gohealth, Inc.'s gross margin was 73.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 10.2 percentage points from the prior year.
Gohealth, Inc.'s net profit margin was -71.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 70.7 percentage points from the prior year.
Gohealth, Inc.'s ROE was -678.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 677.7 percentage points from the prior year.
Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Gohealth, Inc. invested $8.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 39.9% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
GOCO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.9M-5.7% | $12.6M-63.0% | $34.2M-63.7% | $94.0M-57.4% | $221.0M-43.2% | $389.1M+229.0% | $118.3M+11.7% | $105.9M |
| Cost of Revenue | $8.3M+91.3% | $4.3M-78.4% | $20.1M-38.0% | $32.4M-17.5% | $39.3M-24.8% | $52.2M+165.4% | $19.7M-4.8% | $20.7M |
| Gross Profit | $3.6M-56.6% | $8.3M-41.2% | $14.1M-77.1% | $61.6M-66.1% | $181.7M-46.1% | $336.9M+241.6% | $98.6M+15.8% | $85.2M |
| SG&A Expenses | $21.7M+17.2% | $18.5M-33.2% | $27.7M+26.2% | $21.9M-3.2% | $22.7M-28.4% | $31.7M+84.7% | $17.1M+4.5% | $16.4M |
| Operating Income | -$34.8M-7.8% | -$32.3M+88.8% | -$287.9M-189.7% | -$99.4M-1590.3% | $6.7M-91.7% | $80.3M+288.1% | -$42.7M-5.1% | -$40.6M |
| Interest Expense | $30.8M+3.8% | $29.7M+19.8% | $24.8M+46.1% | $16.9M+6.2% | $16.0M-10.0% | $17.7M-7.1% | $19.1M+5.5% | $18.1M |
| Income Tax | $712K+119.8% | -$3.6M-640.3% | -$486K-37.7% | -$353K-132.0% | $1.1M-53.9% | $2.4M+21818.2% | -$11K+72.5% | -$40K |
| Net Income | -$37.2M-14.0% | -$32.6M+80.3% | -$165.8M-205.6% | -$54.3M-1131.3% | -$4.4M-117.3% | $25.5M+276.5% | $6.8M+126.1% | -$26.0M |
| EPS (Diluted) | -$2.36 | N/A | -$11.80-131.4% | -$5.10-880.8% | -$0.52 | N/A | $0.46 | -$2.70 |
Not reported in any period shown, so not listed: R&D Expenses.
GOCO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $917.9M-7.0% | $987.4M-4.2% | $1.0B-21.4% | $1.3B-5.1% | $1.4B-7.1% | $1.5B+11.0% | $1.3B+6.7% | $1.3B |
| Current Assets | $264.9M-7.3% | $285.8M-0.6% | $287.5M-0.5% | $288.8M+10.7% | $260.9M-34.8% | $400.4M+19.9% | $334.0M+10.9% | $301.2M |
| Cash & Equivalents | $39.9M+21.2% | $32.9M+2.6% | $32.1M-9.9% | $35.6M+60.7% | $22.2M-45.9% | $40.9M+15.2% | $35.5M+151.5% | $14.1M |
| Accounts Receivable | $1K-98.6% | $72K+3500.0% | $2K-98.6% | $143K-97.6% | $5.9M+32.4% | $4.5M-35.1% | $6.9M-49.1% | $13.5M |
| Total Liabilities | $915.8M-3.6% | $949.5M-1.3% | $962.3M-14.0% | $1.1B-1.9% | $1.1B-8.5% | $1.2B+10.4% | $1.1B+7.1% | $1.1B |
| Current Liabilities | $130.2M-8.0% | $141.5M-19.5% | $175.7M-5.0% | $185.0M-20.7% | $233.4M-31.0% | $338.1M+19.9% | $282.0M+20.5% | $234.0M |
| Long-Term Debt | $650.8M+2.2% | $636.7M+9.4% | $581.8M+3.9% | $560.0M+25.4% | $446.4M-0.3% | $447.9M+7.6% | $416.3M+0.7% | $413.3M |
| Total Equity | $2.1M-94.4% | $37.9M-44.4% | $68.2M-64.5% | $191.8M-20.6% | $241.6M-0.1% | $241.8M+14.1% | $212.0M+4.6% | $202.7M |
| Retained Earnings | -$717.5M-5.5% | -$680.3M-5.0% | -$647.7M-34.4% | -$481.9M-12.7% | -$427.6M-1.0% | -$423.2M+5.7% | -$448.7M+1.5% | -$455.5M |
Not reported in any period shown, so not listed: Inventory, Goodwill.
GOCO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.0M+117.9% | -$39.1M-19.7% | -$32.7M+13.7% | -$37.8M-204.9% | -$12.4M-184.9% | $14.6M+219.4% | -$12.2M+66.5% | -$36.5M |
| Capital Expenditures | $0 | $0-100.0% | $2.4M-16.2% | $2.8M-7.2% | $3.0M+37.4% | $2.2M-47.8% | $4.3M+57.4% | $2.7M |
| Free Cash Flow | $7.0M+117.9% | -$39.1M-11.6% | -$35.0M+13.8% | -$40.6M-163.0% | -$15.5M-224.8% | $12.4M+175.2% | -$16.5M+58.0% | -$39.2M |
| Investing Cash Flow | $0 | $0+100.0% | -$2.4M+16.2% | -$2.8M+7.2% | -$3.0M-37.4% | -$2.2M-116.7% | $13.3M+591.6% | -$2.7M |
| Financing Cash Flow | -$25K-100.1% | $39.9M+27.0% | $31.4M-41.7% | $53.9M+1785.3% | -$3.2M+54.1% | -$7.0M-134.3% | $20.3M+145.7% | -$44.4M |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
GOCO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.2%-35.4pp | 65.6%+24.4pp | 41.2%-24.3pp | 65.5%-16.7pp | 82.2%-4.3pp | 86.6%+3.2pp | 83.4%+2.9pp | 80.5% |
| Operating Margin | -292.0% | -255.3% | -842.2% | -105.7% | 3.0%-17.6pp | 20.6%+56.7pp | -36.1%+2.3pp | -38.4% |
| Net Margin | -312.0% | -257.9% | -485.1% | -57.7%-55.7pp | -2.0%-8.5pp | 6.6%+0.8pp | 5.7%+30.3pp | -24.6% |
| Return on Equity | -1744.3%-1658.2pp | -86.1%+157.2pp | -243.3%-215.0pp | -28.3%-26.5pp | -1.8%-12.4pp | 10.5%+7.3pp | 3.2%+16.0pp | -12.8% |
| Return on Assets | -4.0%-0.8pp | -3.3%+12.8pp | -16.1%-11.9pp | -4.1%-3.8pp | -0.3%-2.0pp | 1.7%+1.2pp | 0.5%+2.6pp | -2.1% |
| Current Ratio | 2.030.0x | 2.02+0.4x | 1.64+0.1x | 1.56+0.4x | 1.12-0.1x | 1.180.0x | 1.18-0.1x | 1.29 |
| Debt-to-Equity | 305.38+288.6x | 16.81+8.3x | 8.54+5.6x | 2.92+1.1x | 1.850.0x | 1.85-0.1x | 1.96-0.1x | 2.04 |
| FCF Margin | 58.6% | -309.1% | -102.5% | -43.2%-36.2pp | -7.0%-10.2pp | 3.2%+17.1pp | -13.9%+23.1pp | -37.0% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Where Gohealth, Inc. Ranks
Frequently Asked Questions
What is Gohealth, Inc.'s annual revenue?
Gohealth, Inc. (GOCO) reported $361.8M in total revenue for fiscal year 2025. This represents a -54.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Gohealth, Inc.'s revenue growing?
Gohealth, Inc. (GOCO) revenue declined by 54.7% year-over-year, from $798.9M to $361.8M in fiscal year 2025.
Is Gohealth, Inc. profitable?
No, Gohealth, Inc. (GOCO) reported a net income of -$257.1M in fiscal year 2025, with a net profit margin of -71.1%.
What is Gohealth, Inc.'s EBITDA?
Gohealth, Inc. (GOCO) had EBITDA of -$403.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Gohealth, Inc. have?
As of fiscal year 2025, Gohealth, Inc. (GOCO) had $32.9M in cash and equivalents against $636.7M in long-term debt.
What is Gohealth, Inc.'s gross margin?
Gohealth, Inc. (GOCO) had a gross margin of 73.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Gohealth, Inc.'s net profit margin?
Gohealth, Inc. (GOCO) had a net profit margin of -71.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Gohealth, Inc.'s return on equity (ROE)?
Gohealth, Inc. (GOCO) has a return on equity of -678.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Gohealth, Inc.'s free cash flow?
Gohealth, Inc. (GOCO) recorded an outflow of $130.2M in free cash flow during fiscal year 2025. This represents a -268.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Gohealth, Inc.'s operating cash flow?
Gohealth, Inc. (GOCO) recorded an outflow of $121.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Gohealth, Inc.'s total assets?
Gohealth, Inc. (GOCO) had $987.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Gohealth, Inc.'s capital expenditures?
Gohealth, Inc. (GOCO) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Gohealth, Inc.'s current ratio?
Gohealth, Inc. (GOCO) had a current ratio of 2.02 as of fiscal year 2025, which is generally considered healthy.
What is Gohealth, Inc.'s debt-to-equity ratio?
Gohealth, Inc. (GOCO) had a debt-to-equity ratio of 16.81 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Gohealth, Inc.'s return on assets (ROA)?
Gohealth, Inc. (GOCO) had a return on assets of -26.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Gohealth, Inc.'s Piotroski F-Score?
Gohealth, Inc. (GOCO) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Gohealth, Inc.'s earnings high quality?
Gohealth, Inc. (GOCO) reported a net loss of $257.1M while operations used $121.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Gohealth, Inc. cover its interest payments?
Gohealth, Inc. (GOCO) reported an operating loss of $412.9M against $87.3M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.